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Abstract
The mechanisms of inflammation in acne are currently subject of intense investigation. This study focused on the activation
of adaptive and innate immunity in clinically early visible inflamed acne lesions and was performed in two independent
patient populations. Biopsies were collected from lesional and non-lesional skin of acne patients. Using Affymetrix
Genechips, we observed significant elevation of the signature cytokines of the Th17 lineage in acne lesions compared to
non-lesional skin. The increased expression of IL-17 was confirmed at the RNA and also protein level with real-time PCR (RT-
PCR) and Luminex technology. Cytokines involved in Th17 lineage differentiation (IL-1b, IL-6, TGF-b, IL23p19) were
remarkably induced at the RNA level. In addition, proinflammatory cytokines and chemokines (TNF-a, IL-8, CSF2 and CCL20),
Th1 markers (IL12p40, CXCR3, T-bet, IFN-c), T regulatory cell markers (Foxp3, IL-10, TGF-b) and IL-17 related antimicrobial
peptides (S100A7, S100A9, lipocalin, hBD2, hBD3, hCAP18) were induced. Importantly, immunohistochemistry revealed
significantly increased numbers of IL-17A positive T cells and CD83 dendritic cells in the acne lesions. In summary our results
demonstrate the presence of IL-17A positive T cells and the activation of Th17-related cytokines in acne lesions, indicating
that the Th17 pathway is activated and may play a pivotal role in the disease process, possibly offering new targets of
therapy.
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Introduction
Acne is a common disease characterized by androgen depen-
dence, follicular hyperkeratosis, increased sebum excretion,
colonization with Propionibacterium acnes (P. acnes) and inflam-
mation. The earliest subclinical acne lesion is the microcomedo,
which results from increased proliferation and retention of
infundibular keratinocytes [1]. The cytokine IL-1a may have a
role in the initiation of microcomedos, by its ability to induce
hypercornification of keratinocytes [2,3]. The formation of
microcomedos is preceded by mononuclear infiltrates consisting
mainly of CD4+ T-cells and CD68+ macrophages [3]. CD4+ T-
cells are the major leukocytes in the early (6–72 h) inflammatory
infiltrates in acne lesions, with a small portion of CD1+ dendritic
cells. Neutrophils emerge increasingly numerous in the 24 h and
72 h lesions, which are then clinically classified as pustules. At later
time points CD8+ cells infiltrate in the lesions [4,5].
It has been suggested that P. acnes is involved in the triggering
of inflammatory acne via Toll-like receptors (TLRs). The
importance of TLR-mediated immune response is supported by
the presence of TLR2 expressing cells in inflammatory acne
lesions. Furthermore, non-immune cells like keratinocytes and
sebocytes express functional TLR2 [6–12]. P. acnes is considered
to be a trigger of exaggerated TLR2 mediated immune responses
in acne [13]. TLR2 receptors are involved in the recognition of
wide array of microbial molecules mainly in gram-positive
bacteria, and also yeasts [14]. Recently, P. acnes was shown to
activate Nod-like receptor 3 (NLRP3) inflammasome in monocytic
cells leading to the production of IL-1b [15,16]. However, it is still
unclear whether P. acnes can initiate comedogenesis or early
phase inflammatory reaction in acne [17]. Also other triggers than
P. acnes for the early inflammatory cascades in acne lesion
formation for example leukotriens or free fatty acids should be
considered [18].
In addition to innate immunity, also adaptive immunity, and
especially the Th17 pathway, may contribute significantly to the
inflammatory response in acne [18], [19]. Previously P. acnes has
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been shown to stimulate the production of IL-17A and IFN-c in
peripheral blood mononuclear cells (PBMCs) [20–22]. Moreover,
the increased expression of cytokines and other inflammatory
markers such as IL-1a, beta-defensins 1 and 2, TNF-a, IL-1b, IL-
8, IL-10, matrix metalloproteinases MMP-1, MMP-3, MMP-9,
CXCL-2 was found in acne lesions in vivo [3,23–26].
This study was based on the analyses of skin biopsies from
clinically early looking inflamed acne lesions (comedones with
minimal erythematosus flare or small papules). The study material
was recruited by two clinical centers - Oulu, Finland and Berlin,
Germany - with independent groups of patients with acne vulgaris,
as well as psoriasis patients and healthy volunteers as controls. Our
results show that, as in psoriasis, the Th17 pathway is significantly
up-regulated both at the RNA and protein level in lesions of acne
vulgaris. The results suggest a novel pathomechanism in inflam-
matory acne, and open up the possibility for a new class of
therapeutics targeting the Th17 system in severe acne.
Materials and Methods
Ethics statement
The studies presented in this manuscript have been approved by
local Ethics committees of Oulu University Hospital in Finland
and the Charite Universita¨tsmedizin Berlin in Germany. The
biopsies were taken with informed and written consent. All clinical
investigations were conducted in accordance with the Declaration
of Helsinki Principles.
Subjects and sampling
The study was performed in two clinical centers in Oulu,
Finland and Berlin, Germany. A total of 56 acne patients with
moderate to severe acne vulgaris were included in the study.
Clinical characteristic of patients is presented in Tables 1 and 2.
Control subjects comprised patients with psoriasis (n = 9, age
range 28–65; mean 52.9, not age-matched) and healthy volunteers
that had never had acne (n= 6, age range 23–36; mean 26.5). The
inclusion criteria for psoriasis patients were chronic plaque
psoriasis, not receiving systemic or UV-treatment for at least 1
month before sampling. 3 mm (German cohort) or 4 mm (Finnish
cohort) punch biopsies were obtained under local anesthesia from
the back or chest of acne patients from lesional and non-lesional
skin. The acne lesions obtained by biopsy were identified clinically
as early inflammatory acne lesions meaning comedones which
were shading into small red papules (Figure 1). The control skin
biopsies were taken from the back of psoriasis patients lesional and
non-lesional skin and healthy volunteers back skin. Utilization of
all biopsies is described in Figure S1.
Affymetrix
Biopsies for the microarray analysis were stored in RNA
Stabilization Reagent. For RNA extraction the samples were
homogenized with a potter in Qiagen lysis buffer. Total RNA was
extracted using miRNeasy extraction kits according to manufac-
turer’s protocol. RNA quantity was measured using Nanodrop
Table 1. Clinical characteristics of acne patient group from Finland.
Finnish patients (n=20)
Subject Age1 Gender Acne severity2 Technology3
1 21 female 2 RT-PCR and immunohistochemistry
2 24 female 1
3 21 female 2
4 17 female 3
5 34 female 1
6 25 female 1
7 29 female 2
8 22 male 3
9 29 male 3
10 21 male 2
11 26 female 2
12 22 male 3
13 19 male 2
14 27 male 3
15 25 male 1
16 26 male 2
17 25 male 4
18 36 female 1
19 31 female 2
20 18 female 2
Mean 24.9±5.1
1Data are expressed as mean 6SD.
2Acne severity at the biopsy site (back or chest) was assessed by Leeds revised acne grading system in Finnish patient group.
3The technology, which was used to investigate the biopsies taken from the patients.
doi:10.1371/journal.pone.0105238.t001
Th17 Pathway in Acne
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spectrophotometer ND8000. RNA quality was monitored using a
2100 Bioanalyzer (Agilent Technologies, Waldbronn, Germany).
Probes were synthesised and then hybridized on Affymetrix U133
Plus 2.0 chips (Affymetrix, Santa Clara, CA). All chips were
normalized using RMA method [27]. Only Affymetrix identifiers
(IDs) with expression $2exp6 in at least one condition were
selected. Finally, 38014 out of 54675 initially present IDs were
selected. Data analysis was performed on Array Studio software
(OmicSoft, Cary, NC). Mean expression levels were obtained by
calculating the geometrical means of the RMA-normalized data
for involved and non-involved sample groups, respectively. A two
sided paired T test was performed using Array Studio (OmicSoft
Corporation, USA), to determine which genes were significantly
differentially expressed between involved and non-involved
groups, and Benjamini-Hochberg false discovery rate (FDR)
Table 2. Clinical characteristics of acne patient group from Germany.
German patients (n=36)
Subject Age1 Gender Acne severity2 Technology3
1 18 male Severe Affymetrix and RT-PCR
2 19 male Severe
3 20 female Moderate
4 21 male Severe
5 28 male Moderate
6 26 male Severe
7 22 male Severe
8 30 male Mild
9 23 male Severe
10 24 male Moderate
11 19 male Severe
12 26 male Mild
13 25 male Moderate Luminex
14 20 male Severe
15 28 male Moderate
16 27 male Moderate
17 21 male Moderate
18 22 male Mild
19 25 male Moderate
20 19 male Severe
21 20 male Mild
22 29 female Moderate
23 31 male Severe
24 31 male Moderate
25 18 male Severe Immunohistochemistry
26 19 male Moderate
27 29 male Severe
28 24 male Severe
29 30 male Severe
30 20 male Moderate
31 19 male Moderate
32 19 female Moderate
33 27 female Severe
34 29 male Moderate
35 22 male Severe
36 21 male Moderate
Mean 23.6±4.2
1Data are expressed as mean 6SD.
2Acne severity at the biopsy site (back) was assessed by Global Evaluation Acne scale in German patient group.
3The technology, which was used to investigate the biopsies taken from the patients.
doi:10.1371/journal.pone.0105238.t002
Th17 Pathway in Acne
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multiple testing correction [28] was applied. The raw data is
available at NCBI GEO, accession number GSE53795.
RT-PCR analysis
Snap frozen skin biopsies were homogenized in Trisure (Bioline,
London, UK) and RNA was extracted according to standard
protocols and subjected for cDNA synthesis. Complementary
DNA synthesis, and RT-PCR analysis were performed as
previously described [29] with 7500 Fast Real Time PCR-system
(Applied Biosystems, Foster City, CA) in Finland and Applied
Biosystems 7900HT machine in France. The data were analysed
by using the 22(DDCt) method, according to the manufacturer’s
instructions. Statistical analyzes were done with Student’s t-test or
when variances were significantly different, with nonparametric
Mann-Whitney U test using GraphPad Prism software (GraphPad
Software Inc., LaJolla, CA).
Cytokine profiling by Luminex technology
Cytokines were extracted from non-lesional and lesional skin
which were crushed manually for 4 minutes with a glass potter
(Dominique Dutscher S.A, Brumath, France) in 200 mL ice-cold
PBS containing Triton X100 0, 2% and protease inhibitors
(cOmplete, Mini, EDTA-free) (Roche Applied Science, Mann-
heim, Germany). Samples were stirred for 30 minutes at 4 u, at
1400 RPM and then centrifuged for 5 minutes at 4uC, at 10 000
RPM. Supernatants were harvested and the concentration of
proteins was determined by colorimetric method (Bio-Rad DC
Kit)(Bio-Rad Laboratories, Hercules CA). Cytokines were quan-
tified in duplicate using following Luminex assays (Life Technol-
ogies, Carlsbad, CA): Human Cytokine, Premixed 23 Plex,
Immunoassay Procarta kit and Milliplex Human Cytokine,
Premixed 42 Plex, Immunoassay kit (Merck Millipore, Billerica,
MA). Cytokine quantitities were normalized to the total concen-
tration of protein.
Histology and immunohistochemistry
Biopsies for histological analysis were fixed in 10% buffered
formaldehyde. After dehydration/impregnation and inclusion in
paraffin, 4 mm-thick serial sections were prepared. Slides were
stained using Hematoxylin-Eosin.
For immunohistochemistry of German patient samples, depar-
affinised sections were treated for antigen retrieval in 10 mM
citrate buffer, pH 6.0 at 98uC for 20 minutes. Mouse antihuman
CD3 (clone Ab-9, Thermo Scientific, Fremond, CA) was used to
detect T-lymphocytes. IL-17A was detected on the same section
with a goat polyclonal antihuman IL-17A antibody (R&D systems,
Minneapolis, MN). CD3 was detected with Alexa fluor 594
conjugated antibody and IL-17A was revealed after amplification
(Biotin/ Streptavidin FITC). Positive cells were counted visually
on slides scanned with the NanoZoomer (Hamamatsu, Japan).
For immunohistochemistry of Finnish samples, heat-induced
antigen retrieval of the deparaffinised sections was performed in a
microwave oven. Endogenous peroxidase activity was neutralized.
The sections were incubated with monoclonal mouse anti-human
Figure 1. Macroscopic appearance of biopsied lesions from acne patients.
doi:10.1371/journal.pone.0105238.g001
Th17 Pathway in Acne
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antibodies to CD4 (clone 4B12, 1:50, Novocastra, Newcastle, UK),
CD8 (clone 4B11, 1:200, Novocastra), CD68 (clone KP-1,
1:10000, Dako, Copenhagen, Denmark), CD83 (clone 1H4b,
1:25, Dako), Foxp3 (clone 236A/E7, 1:100, Abcam Ltd., Cam-
bridge, UK), T-bet (clone 4B10, 1:200, Abcam Ltd.) and goat
polyclonal anti-human antibody to IL-17A (1:100, R&D systems,
Minneapolis, MN). Bound antibodies were detected using the
NovoLink Polymer detection system (Leica Biosystems, Newcastle,
UK), the EnVision system (Dako) or Goat-HPR-Polymer kit
(Biocare Medical, Concord, CA). Deaminobenzidine (DAB) was
used as the chromogen and hematoxylin as the counterstain.
Digital image analysis was used to count the positive cells. The
digital images were obtained under 206 magnification from all
sections with the use of a Nikon Eclipse E600 microscope and a
Olympus DP25 digital camera. Images were taken from upper
dermal area and around pilosebaceous follicles, resulting in 2 to 7
images per slide. Image analysis was performed as described
previously using ImageJ software [30] to record the average
number of the positively stained cells per 206 field image
(0.14 mm2). Data are presented as median positive cell count
(interquartile range). The statistical analysis was performed by
IBM SPSS Statistics 19 (IBM, Chicago, IL). Mann-Whitney U test
two-tailed p-value less than 0.05 was considered statistically
significant.
Results
Genome-wide transcriptome reveals Th17-related
signaling significantly elevated in acne lesions
The study was performed in two separate patient cohorts from
Germany and Finland (Tables 1 and 2). The gene expression in
skin biopsies of the subjects recruited in Germany was screened
using Affymetrix microarray technology. In the array analyses, a
total of 904 genes were differentially expressed in acne lesions
compared with non-lesional skin, and 509 of these were
upregulated, whereas 395 were downregulated (Tables 3 and 4).
All microarray data have been deposited in NCBI’s Gene
Expression Omnibus [31] and are accessible through GEO series
Table 3. Top 20 up-regulated genes in the German acne patient group based on Affymetrix microarray technology.
ProbeSet Gene symbol Title
Mean expression
(non-involved skin)
Fold change
(involved vs.
non-involved skin) FDR
232170_at S100A7A S100 calcium binding protein A7A 235 29 ,0.001
202859_x_at IL8 interleukin 8 162 25 ,0.001
207356_at DEFB4 defensin, beta 4 451 25 ,0.001
211906_s_at SERPINB4 serpin peptidase inhibitor, clade B
(ovalbumin), member 4
768 19 ,0.001
204475_at MMP1 matrix metallopeptidase 1 (interstitial
collagenase)
124 19 ,0.001
212768_s_at OLFM4 olfactomedin 4 65 16 0.0018
205828_at MMP3 matrix metallopeptidase 3 (stromelysin 1,
progelatinase)
79 16 ,0.001
204470_at CXCL1 chemokine (C-X-C motif) ligand 1
(melanoma growth stimulating activity, alpha)
51 15 ,0.001
210873_x_at APOBEC3A apolipoprotein B mRNA editing enzyme,
catalytic polypeptide-like 3A
53 14 ,0.001
205863_at S100A12 S100 calcium binding protein A12 47 14 ,0.001
203691_at PI3 peptidase inhibitor 3, skin-derived 987 13 ,0.001
209875_s_at SPP1 secreted phosphoprotein 1 96 13 ,0.001
206561_s_at AKR1B10 aldo-keto reductase family 1, member B10
(aldose reductase)
135 13 ,0.001
205681_at BCL2A1 BCL2-related protein A1 81 13 ,0.001
206336_at CXCL6 chemokine (C-X-C motif) ligand 6 (granulocyte
chemotactic protein 2)
13 11 ,0.001
209774_x_at CXCL2 chemokine (C-X-C motif) ligand 2 54 11 ,0.001
204580_at MMP12 matrix metallopeptidase 12 (macrophage
elastase)
67 11 ,0.001
205114_s_at CCL3/CCL3L1/
CCL3L3
chemokine (C-C motif) ligand 3/ chemokine
(C-C motif) ligand 3-like 1/chemokine
(C-C motif) ligand 3-like 3
65 10 ,0.001
210146_x_at LILRB2 leukocyte immunoglobulin-like receptor,
subfamily B (with TM and ITIM domains),
member 2
32 10 ,0.001
210413_x_at SERPINB3/SERPINB4 serpin peptidase inhibitor, clade B
(ovalbumin), member 3/ serpin peptidase
inhibitor, clade B (ovalbumin), member 4
1936 10 ,0.001
doi:10.1371/journal.pone.0105238.t003
Th17 Pathway in Acne
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accession number GSE53795. A two-component Non Negative
Matrix Factorization (NMF) model [32] was applied and allowed a
clear separation between lesional and non-lesional acne samples
(Figure 2). Bioinformatic analysis of differentially modulated genes
using Metacore software identified the inflammatory and immune
responses as the main enriched biological processes (Figure 3a).
Interestingly, the IL-17 signaling pathway and the Th17-derived
cytokines network were ranked fourth in the enriched GeneGo
pathways and networks, respectively (Figures 3b and 3c).
Table 4. Top 20 down-regulated genes in the German acne patient group based on Affymetrix microarray technology.
ProbeSet Gene symbol Title
Mean
expression
(non-involved
skin)
Fold change
(involved vs.
non-involved
skin) FDR
204515_at HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid
delta-isomerase 1
2897 28.8 0.002
205380_at PDZK1 PDZ domain containing 1 1914 26.4 0.002
210576_at CYP4F8 cytochrome P450, family 4, subfamily F, polypeptide 8 1305 26.3 0.002
241412_at BTC betacellulin 791 26.1 ,0.001
234513_at ELOVL3 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3,
yeast)-like 3
8094 26.1 0.003
1553583_a_at THRSP thyroid hormone responsive (SPOT14 homolog, rat) 5008 25.9 0.003
206143_at SLC26A3 solute carrier family 26, member 3 166 25.7 ,0.001
234980_at TMEM56 transmembrane protein 56 3401 25.4 0.002
220801_s_at HAO2 hydroxyacid oxidase 2 (long chain) 1120 25.3 ,0.001
230573_at SGK2 Serum/glucocorticoid regulated kinase 2 495 25.3 0.0016
207958_at UGT2A1/UGT2A2 UDP glucuronosyltransferase 2 family, polypeptide A1/UDP
glucuronosyltransferase 2 family, polypeptide A2
351 25.0 ,0.001
206465_at ACSBG1 acyl-CoA synthetase bubblegum family member 1 8201 24.9 0.002
208962_s_at FADS1 fatty acid desaturase 1 5240 24.8 0.003
205029_s_at FABP7 fatty acid binding protein 7, brain 4530 24.8 0.011
239108_at FAR2 Fatty acyl CoA reductase 2 6891 24.7 0.002
210377_at ACSM3 acyl-CoA synthetase medium-chain family member 3 591 24.5 0.003
206714_at ALOX15B arachidonate 15-lipoxygenase, type B 6853 24.5 0.003
221142_s_at PECR peroxisomal trans-2-enoyl-CoA reductase 1668 24.5 0.0012
236175_at TRIM55 tripartite motif-containing 55 184 24.4 ,0.001
208331_at BPY2 basic charge, Y-linked, 2 1084 24.4 0.007
doi:10.1371/journal.pone.0105238.t004
Figure 2. 2-components NMF (Non Negative Matrix Factorization) model. The heatmap of 904 regulated genes on subjects-corrected log2-
expressions (legend color blue for low expression and red for high expression).
doi:10.1371/journal.pone.0105238.g002
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The Affymetrix transcriptome results were confirmed with real-
time PCR (RT-PCR). Among the upregulated genes were IL-23,
IL-6 and TGF-b, which all are critically involved in Th17 cell
activation and differentiation. Furthermore, Th17 cell products
IL-17A, IL-22, IL-26, TNF and IL-17 induced chemokines CSF2
and CCL20 were also expressed at higher levels in acne lesions
(Table 5). The expression of the upregulated genes of Th17
lineage inducing cytokines IL-1b, IL-6, TGF-b and IL-23 were
found significantly increased also in the Finnish cohort by RT-
PCR (Figure 4) as well as Th17 signaling cytokine IL-17A.
The increased production of Th17 related cytokines in the acne
lesions was confirmed at the protein level by cytokine profiling of
manually crushed skin biopsies from German patients by Luminex
technology (Table 6). Furthermore, significantly higher numbers
of IL-17A positive (IL-17A+) cells were detected by immunohis-
tochemistry both in the papillary dermis and around sebaceous
follicles in acne lesions of Finnish patients (Table 7). IL-17A+ cells
were scattered in the superficial and deep layers of the dermis
(Figure 5a). IL-17A+ cells were mainly lymphocytes but some of
them were neutrophils and even mast cells (data not shown). IL-
17A+ cells were also identified in the inflammatory infiltrates in
the German patient group (Figure 5b). Strongly IL17-positive cells
were mainly composed of CD3+ lymphocytes in both lesional and
non-lesional samples.
Thus, the upregulation of Th17 pathway found with global
Affymetrix analysis was confirmed with RT-PCR and also on the
protein level with Luminex and immunohistochemistry in patient
samples from Germany. Moreover, the result was similar in a
separate patient group from Finland investigated by RT-PCR and
immunohistochemistry. While IL-17A in addition to Th17 cells
can also be secreted by other CD3+ lymphocytes, including CD8+
cytotoxic T-cells (Tc17) and cd T cells, the concomitantly
observed inductions of Th17-activating and Th17-related cyto-
kines and chemokines observed in two independent patient
populations support the observation of Th17 pathway activation
in acne lesions.
Innate immune responses were significantly increased in
acne lesions
We wanted to investigate also innate immune responses in acne
lesions. P. acnes triggers inflammatory responses via TLR2 or
Nod-like receptor 3 (NLRP3) -inflammasome, leading to the
production of IL-6, and IL-8 by keratinocytes and sebocytes and
IL-1b, IL-12 and IL-8 by macrophages and primary monocytes,
respectively [15,16,33–35]. The expression of TLR2 and TLR4
were significantly elevated in the acne lesions in the Finnish group
(Figure 6a). Of note, TLR2, but not TLR4, was increased in
psoriasis control samples as found earlier by Begon et al [36]. The
Figure 3. Bioinformatic analysis of differentially modulated genes. Gene enrichment analysis in three different functional ontologies were
performed using MetaCore: biological processes (a), process networks (b) and canonical pathway maps (c).
doi:10.1371/journal.pone.0105238.g003
Th17 Pathway in Acne
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proinflammatory cytokines IL-1b, IL-6, TNF-a and the chemo-
kine IL-8 were all expressed at a higher level in acne lesions in the
Finnish cohort (Figure 4, Figure 6b). Similarly, TLR2 and TLR4
as well as IL-8, IL-6, and TNF-a, were induced in acne lesions in
the German group (Table 8).
The expression of antimicrobial peptides (AMPs) was also
increased in the acne lesions. AMPs are evolutionary conserved,
positively charged molecules that bind membranes of microbes by
their hydrophobic surfaces and form pores on the membranes and
limit the survival of commensals and potential pathogens also with
other mechanisms [37]. The expression of AMPs human
cathelicidin antimicrobial protein (hCAP18), lipocalin (LCN2),
human beta-defensin 2 (hBD2), hBD3, S100A7 and S100A9 were
found significantly upregulated in acne lesions in the Finnish
patient group by RT-PCR (Figure 7). Similar findings were
observed in German patients (Table 9).
Th1 and T regulatory cell markers were elevated at the
RNA level in acne lesions
In addition to the Th17 pathway, we examined other T-cell
subsets in acne lesions. Mouser and co-workers [38] demonstrated
a subpopulation of Th1 cells generated from early inflamed acne
lesions, but regulatory T cells (Tregs) are not investigated in acne
lesions. IL-12 is a pivotal cytokine in activating Th1 responses, and
is induced in monocytes by P. acnes via TLR2 [6] and in vitro in
PBMCs [20]. The IL-12 subunit p40, but not p35, was found
significantly increased in both acne (P,0.01) and psoriasis (P,
0.001) by RT-PCR (Figure 8). Furthermore, the Th1 polarizing
key transcription factor T-bet, Th1 effector cytokine IFN-c, and
Th1 type chemokine receptor CXCR3 were also expressed at a
higher level in both acne and psoriasis lesions, indicating the
involvement of Th1 effector cells (Figure 8). Similar findings were
observed in the German cohort, since STAT1 a positive regulator
Figure 4. Th17 related cytokines were increased in acne lesions. The skin biopsies were obtained from healthy volunteers normal skin (NS),
from acne patients non-lesional skin (A NS) and lesional skin (AL) and from psoriasis patients non-lesional skin (P NS) and lesional skin (PL). The
expression levels of cytokines were determined by RT-PCR. The expressions of inflammatory cytokines TGF-b, IL-6, IL-1b and IL-23 were increased
significantly both in acne and psoriasis but IL-1b and TGF-b expression was higher in acne. IL-23 was increased more in psoriasis lesions. IL-17A was
significantly expressed in lesional acne and psoriasis skin. IL-22, was slightly elevated in acne and psoriasis, however significantly more in psoriasis.
*P,0.05, **P,0.01, ***P,0.001; bars represent mean +SEM. RU, relative units; TGF-b, transforming growth factor- beta; Th17, T helper type 17.
doi:10.1371/journal.pone.0105238.g004
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of Th1 development was induced, and the CXCR3 ligands
CXCL9, CXCL10 and CXCL11, were overexpressed in lesional
acne skin (Table 10).
Foxp3 is a specific marker of natural and induced Tregs, which
are efficient suppressors of both innate and adaptive immune
responses. TGF-b and IL-10 are involved in the induction and
function of Tregs [39]. In the Finnish cohort, the expression of
Foxp3, TGF-b and IL-10 were found significantly up-regulated in
acne lesions by RT-PCR, and the latter two were at higher levels
in acne lesions compared with psoriatic lesions (Figure 8). In the
German cohort, TGF-b and IL-10 displayed a slightly enhanced
expression in acne lesions and also the expression of Foxp3 was
detected (Table 11).
Th2 cells produced cytokines IL-4, IL-5 and IL-13 were either
not detected or not modulated in the German cohort by array
technology, and detected at a very low level in the Finnish cohort
by RT-PCR, suggesting that Th2 cells are not involved in the
inflammatory response in acne and in psoriasis (data not shown).
Cells of adaptive immunity were recruited to acne lesions
In addition to measurement of gene expression in skin samples,
we investigated the infiltration of key cell types in acne lesions.
Apart from IL-17A, skin biopsy tissue sections were stained for
CD4, CD8, T-bet, Foxp3, CD68 and CD83. All sections of
lesional and non-lesional acne samples contained immune cells in
papillary dermis and around sebaceous follicles. The most
common cells were CD68+ macrophages and CD4+ T-cells.
The count of CD4+ cells and CD83+ mature dendritic cells was
significantly higher both in the papillary dermis and around
follicles in acne lesions, when compared with non-lesional skin.
(Figure 5e–h, Table 7). T-bet+ cells were also detected both in
lesional and non-lesional skin of acne patients, but at significantly
higher numbers in acne lesions, both in the papillary dermis and
Table 6. Expression at the protein level of markers and cytokines characterizing the Th17 cell subtype in the German acne cohort.
Th17 Signalling Symbol Title
Protein level pg/mg
(non-involved skin)
Fold change (involved
vs. non- involved skin)
P-value (involved vs.
non- involved skin)
Th17 activation IL23 interleukin 23, alpha
subunit p19
0.3 3.1 0.17
IL6 interleukin 6 1.1 15.0 ,0.001
Th17 related cytokines
and chemokines
IL17A interleukin 17A 1.1 3.8 0.01
IL17F interleukin 17F 0.3 4.9 ,0.001
IL22 interleukin 22 4.6 3.1 0.03
IL6 interleukin 6 1.1 15.0 ,0.001
TNF transforming growth
factor, beta 1
1.1 2.5 0.02
CCL20 chemokine (C-C motif)
ligand 20
0.4 2.6 0.04
IL21 interleukin 21 7.5 3.9 0.01
CSF2 colony stimulating factor 2 1.1 2.2 0.01
doi:10.1371/journal.pone.0105238.t006
Table 7. Number of positively stained cells in lesional and non-lesional skin of acne patients (n = 16)1 as assessed by
immunohistochemistry.
Positive-cell counts2 in upper dermis Positive-cell counts2 around follicles
Lesional Non-lesional P-value Lesional Non-lesional P-value
CD4 33 (22–52.8) 16.5 (9.3–26.3) 0.007 52 (44–127.5) 8 (4–14.5) 6.561025
CD8 6 (2.3–15.3) 3 (1.3–9.5) 0.225 11 (4.5–18.5) 1 (1–2) 8.561025
T-bet 6 (3–17) 2.5 (1–3) 0.005 16.5 (3.5–31.5) 0 (0–1.8) 8.661025
IL–17A 4.5 (2.3–8) 2 (2–3) 0.030 6 (3.5–9.3) 3 (1.3–5.3) 0.023
Foxp3 4.5 (2–9.8) 1 (1–3) 0.003 6 (0.8–13) 1 (1–2) 0.072
CD68 38 (18.3–68) 5.5 (1–13) 3.1610–5 77.5 (27–131.5) 3.5 (2.3–5.8) 2.661025
CD83 7 (2.3–13) 1.5 (0.3–2.8) 1.5610–4 12 (4.5–27) 1 (0–2) 2.361026
Abbreviations: IHC, immunohistochemistry; IQR, interquartile range.
116 of total 20 acne patients samples in Finnish patient cohort were examined by IHC.
2Positive-cell counts per field image are expressed as medians (IQR). Statistically significant difference of P,0.05 in the lesional acne skin compared to non-lesional skin.
Significant P values are bold.
doi:10.1371/journal.pone.0105238.t007
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around follicles, demonstrating the presence of Th1 cells
(Figure 5c, Table 7). Yet, the number of Foxp3+ cells was
significantly higher in the acne lesions in the papillary dermis
but not around follicles (Figure 5d, Table 7). Finally, the count of
CD8+ T-cells was significantly higher in infiltrates around follicles
in lesional acne (Table 7).
Discussion
In the current study we examined the inflammatory reaction
and especially the IL-23/Th17/IL-17A axis in lesions of acne in
vivo. Our results in two independent groups of acne patients show
that the cytokines involved in the differentiation of Th17 cells and
the expression of the main effector cytokines IL-17A and IL-17F
were significantly expressed in lesions of acne at mRNA and
protein level.
Figure 5. Inflammatory cell infiltrates of early acne lesions in immunohistochemistry. Representative immunohistochemical staining
showing IL-17A+ cells in early acne lesion (a). Staining of IL-17A+ and CD3+ cells shows that IL-17A (in green) and CD3 (in red) were detected in acne
vulgaris lesions. Cell nuclei were counterstained in blue. Arrows indicate IL-17A and CD3 double positive cells (b). T-bet+ cells (c) were more
numerous than IL-17A+ cells or Foxp3+ cells (d) in the lesional acne skin. Large number of CD4+ cells (e), mostly lymphocytes, was seen around
pilosebaceous unit and perivascularly. CD8+ cells (f) were fewer in number than CD4+ cells. Large number of CD68+ macrophages (g) and a few
CD83+ cells (h), which are mature dendritic cells, were detected around sebaceous follicles. (Bar = 200 mm; in the insets bar = 50 mm).
doi:10.1371/journal.pone.0105238.g005
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IL-17A and IL-17F are key cytokines for the recruitment and
activation of neutrophils and can target different cell types
including keratinocytes, endothelial cells, monocytes, fibroblasts
to induce pro-inflammatory mediators IL-6, TNF-a, IL-1b, PGE2,
nitric oxide, matrix metalloproteinases and chemokines (GM-CSF,
G-CSF, CXCL1, CXCL8, CCL2, CCL7, CCL20) [40]. In
psoriasis IL-17A, IL-17F, IL-22 and IL-20 act on keratinocytes
leading to epidermal hyperplasia [41,42]. IL-22, which is secreted
by both Th17 and Th22 cells [40], induces the production of IL-
20 [43]. In our study elevated levels of IL-22 (Figure 4, Table 5)
and IL-20 (Figure 6c) were found in acne lesions by RT-PCR. IL-
17 and IL-22 induces the production of AMPs [44]. The
expression of AMPs was up-regulated in acne, which confirms
prior observations [23,26,45–48]. Probably due to the high level of
Figure 6. The expression of proinflammatory mediators in Finnish patient cohort examined by RT-PCR. The expression of a) toll-like
receptors TLR2 and TLR4, b) proinflammatory cytokine TNF-a and neutrophil chemotactic factor IL-8 were significantly up-regulated in lesional acne.
c) IL-20 mRNA were increased in acne and psoriasis lesions. It is known that IL-20 can stimulate epidermal hyperplasia in model systems and is
upregulated in psoriasis. *P,0.05, **P,0.01, ***P,0.001; bars represent mean 6SEM.
doi:10.1371/journal.pone.0105238.g006
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AMPs, acne and psoriasis are seldom complicated by secondary
infections.
We found increased expressions of pro-inflammatory cytokines
IL-1b, IL-6, TNF-a and TGF-b that are also important in Th17
cell activation. All these cytokines enhance generation of Th17
cells from naive T-cells with activated dendritic cells in the
presence of IL-23 [40]. TGF-b is a critical cytokine in both Th17
and Treg-cell differentiation. TNF-a can synergize with IL-17 to
promote inflammation in psoriasis and also IL-17 and IFN-c
synergize in pro-inflammatory cytokine production in keratino-
cytes [49], [50]. On the contrary to Agak et al [20], we found also
increased expression of Th17 cells stabilizing cytokine IL-23p19
both at the RNA and protein level in vivo. IL-23 is secreted by
activated dendritic cells and macrophages and situations in vitro
Table 8. Expression at the mRNA level of proinflammatory mediators in the German acne cohort determined by Affymetrix
microarray technology.
Gene
symbol Title
Mean expression (non-
involved skin)
Fold change (involved vs.
non- involved skin)
FDR (involved vs. non-
involved skin)
TLR2 toll-like receptor 2 682 1.9 0.006
TLR4 toll-like receptor 4 126 2.1 0.0006
IL6 interleukin 6 73 4.7 0.001
TNF tumor necrosis factor 80 1.6 0.003
IL8 interleukin 8 162 24.7 0.0001
Abbreviations: FDR, false discovery rate.
doi:10.1371/journal.pone.0105238.t008
Figure 7. Antimicrobial peptides are increased in acne and psoriasis lesions by RT-PCR. The expressions of mRNAs were significantly
higher in psoriasis except for hCAP-18, which was similarly expressed in both. *P,0.05, **P,0.01, ***P,0.001; bars represent mean 6SEM. BD2,
human beta-defensin 2; BD3, human beta-defensin 3; hCAP-18, human cathelicidin antimicrobial protein 18; LCN2, lipocalin-2; RU, relative units.
doi:10.1371/journal.pone.0105238.g007
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Table 9. Expression at the mRNA level of antimicrobial peptides in the German acne cohort determined by Affymetrix microarray
technology.
Gene symbol Title
Mean expression (non-
involved skin)
Fold change (involved vs.
non- involved skin)
FDR (involved vs. non-
involved skin)
CAMP cathelicidin antimicrobial peptide 121 1.5 0.004
DEFB103A defensin, beta 103B 117 1.9 0.0001
DEFB4A defensin, beta 4A 451 24.6 0.0001
LCN2 lipocalin 2 1 998 2.6 0.004
S100A7 S100 calcium binding protein A7 7 058 4.1 0.0004
S100A9 S100 calcium binding protein A9 4 086 5.9 0.0003
Abbreviations: FDR, false discovery rate.
doi:10.1371/journal.pone.0105238.t009
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and in vivo are different. Our results are in line with the prior
observations concerning up-regulated TNF-a and IL-1b in acne
lesions examined by RT-PCR [25]. Recently P. acnes is identified
as a trigger of monocyte-macrophage NLRP3- inflammasome
activation and IL-1b processing and secretion, and further as a
trigger of an innate immune response in the skin [15]. The
expression of cytokines IL-6, IL-12p40, INF-c and TGF-b have
not been studied earlier in acne lesions as also noticed by
Thiboutot and co-workers [19], nor cytokines IL-17A, IL-17F, IL-
23p19, IL-22 and chemokines CCL20 and CSF2. The IL23/Th17
pathway and especially cytokine IL-17A is a key cytokine that
activates pathogenic inflammation in psoriasis [51], [52]. We
hypothesize that follicular hyperkeratinization, increased expres-
sion of AMPs and accumulation of neutrophils in acne lesions may
be in part explained by the activation of the IL-23/IL-17 axis
(Figure 9).
Previously described CD4+ T cells in early acne lesions have not
been determined in details [4,5]. We defined the markers of T cell
subsets at mRNA level and studied Th1 (T-bet), Th17 (IL-17A),
Treg (Foxp3) cells, cytotoxic CD8+ T-cells and CD68 macro-
phages and CD83 positive activated dendritic cells in clinically
early acne lesions by immunohistochemistry both phenotypically
and proportionally (Figure 5, Table 7). Recently Agak and co-
workers [20] presented IL-17+ lymphoid cells in three closed
comedone-type acne lesions by immunohistochemistry. In addi-
tion to Th17 cells IL-17A can also be secreted by CD8+ cytotoxic
T-cells (Tc17), ab and cd T cells and even neutrophils and mast
cells [53]. In our study the observations of IL-17A+ by
immunohistochemistry resembled the findings made by Res et al
[54] in psoriasis. The cells were few and they were scattered
throughout the samples (Table 7, Figure 5a), however, significant-
ly more numerous in lesional areas. IL-17A+ cells were mainly
lymphocytes but some of them were neutrophils and even mast
cells. Further investigations are needed to examine whether CD8+
cells in acne lesions were either Tc17 or Tc22 cytotoxic cells. To
examine early CD4+ reaction, biopsies were taken from small
visible developing papules for microarray/RT-PCR and immu-
nohistochemistry. Previously Norris and Cunliffe have described
the biopsied 6-72 h lesions had morphology of small papules with
a minimal surrounding erythematous flare, in which lymphoid
cells outnumbered polymorphonuclear cells (PMNs) in the 6 h
biopsies and PMNs became increasingly numerous in the 24-72 h
lesions [5]. In our study the biopsied lesions were similar in
appearance: comedones with erythematous flare or small papules
(Figure 1). The lesions in immunohistochemistry revealed neutro-
phils in many of the lesions but fewer than lymphoid cells and
moreover the rupture of the follicle walls was not usually seen
suggesting the biopsied lesions were not fully developed inflam-
matory lesions.
To best of our knowledge Treg cells have not been examined in
acne lesions earlier. We found significantly increased number of
Foxp3+ cells in papillary dermis in immunohistochemistry. Tregs
prevent autoimmunity and suppress immune responses. Retinoic
acid can regulate reciprocally Tregs and Th17 via TGF-b -
dependent generation of Foxp3 [55], [56], a mechanism that may
be of importance in the treatment of acne by isotretinoin. Elevated
serum levels of anti-inflammatory cytokine IL-10 are found in acne
patients and the expression of IL-10 is increased in acne lesions
[13], [25]. In our study lesional IL-10 mRNA was higher in acne
than in psoriasis (Figure 8). Of note, TLR2 recognition of Candida
albicans suppresses inflammatory responses via production of IL-
10 and enhanced Treg survival [14] but it is not known if TLR2
recognition in acne has the same consequences. Though acne is
often a chronic disease, a single acne lesion is seldom secondarily
Figure 8. The expression of Th1 cell and Treg markers were activated in acne by RT-PCR. Th1 transcription factor T-bet, Th1 cell surface
chemokine receptor CXCR3 and IFN-c (the effector cytokine of Th1 cells) mRNAs were significantly up-regulated in acne and psoriasis lesions. The
transcription factor of Tregs, Foxp3, was elevated in acne and psoriasis. TGF-b which is both Th17 and Treg lineages inducing cytokine was
significantly increased in acne lesions. The product of Tregs, immunosuppressive cytokine IL-10 was expressed more in acne than in psoriasis. *P,
0.05, **P,0.01, ***P,0.001; bars represent mean 6SEM. RU, relative units; TGF-b, transforming growth factor- beta; Th1, T helper type 1; Treg,
regulatory T cell.
doi:10.1371/journal.pone.0105238.g008
Table 10. Expression at the mRNA level of markers and cytokines characterizing the Th1 cell subtype in the German acne cohort
determined by Affymetrix microarray technology.
Gene symbol Title
Mean expression (non-
involved skin)
Fold change (involved
vs. non- involved skin)
FDR (involved vs. non-
involved skin)
CXCL10 chemokine (C-X-C motif) ligand 10 131 3.1 0.01
CXCL11 chemokine (C-X-C motif) ligand 11 24 2.8 0.05
CXCL9 chemokine (C-X-C motif) ligand 9 131 2.3 0.04
CXCR3 chemokine (C-X-C motif) receptor 3 86 1.1 0.03
STAT1 signal transducer and activator of
transcription 1
500 2.2 0.01
TBX21 T-box 21 65 1.2 0
IL12B interleukin 12B (p40) Not detected NA NA
IL12A interleukin 12A (p35) Not detected NA NA
IFNG interferon, gamma Not detected NA NA
Abbreviations: FDR, false discovery rate; NA, Not applicable.
doi:10.1371/journal.pone.0105238.t010
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infected and is rapidly demarcated. The increased IL-10
expression and Tregs may demarcate the inflammation of a single
acne lesion efficiently from the beginning. The reaction soon
changes after ruptures of follicular walls into the direction of
wound healing and fibrosis [34].
In conclusion, we demonstrated the presence of IL-17A+ cells,
which were mainly lymphocytes, in clinically early visible inflamed
acne lesions, and also the activation of cytokines, chemokines and
antimicrobial peptides known to be typical for the Th17/IL-17
pathway. Th1, Th17 and also CD8+ activation and IL-17 related
AMP and CXCL chemokine production with neutrophil attrac-
tion in acne lesions could be important factors among others in
acne pathogenesis. Further studies will show the relevance of these
findings also in the pathogenesis of different variations of severe
acne such as acne cystica, acne fulminans and autoinflammatory
syndromes with acne symptoms like SAPHO or PAPA syndromes,
and indicate new possibilities to target the inflammatory response
in acne diseases.
Table 11. Expression at the mRNA level of markers and cytokines characterizing the Treg cell subtype in the German acne cohort
determined by Affymetrix microarray technology.
Gene symbol Title
Mean expression
(non-involved skin)
Fold change (involved vs.
non- involved skin)
FDR (involved vs. non-
involved skin)
FOXP3 forkhead box P3 62 1.2 0.002
IL10 interleukin 10 31 1.9 0.002
TGFB1 transforming growth factor, beta 1 111 1.8 0.001
Abbreviations: FDR, false discovery rate.
doi:10.1371/journal.pone.0105238.t011
Figure 9. The effect of IL-17 on keratinocytes. Th17-cells are defined to secrete IL-17 cytokines. Also some other cells can secrete IL-17 cytokines
when properly activated. IL-17A and IL-17F regulate genes on keratinocytes, that are involved in innate immune defence, such as antimicrobial
peptides (beta-defensins, S100 proteins A7/9, cathelicidin, LCN2) and a range of chemokines G-CSF, CXCLs and CCL20 which regulate neutrophil and
lymphocyte trafficking. IL-17A and IL-17F stimulate keratinocytes leading to keratinocyte proliferation. Also vascular inflammation is activated.
doi:10.1371/journal.pone.0105238.g009
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Supporting Information
Figure S1 A flowchart of the experimental design. The
figure clarifies the methods used in the different cohorts of the
study.
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